Dr. Gerald Diaz @GeraldMD
50.4M 14.4K 7.6K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
3 results
copd management asthma daliresp diagnosis differences firstline gold2017 indications laba lama overlap pharmacology pulmonary roflumilast treatment
Daliresp (Roflumilast) Indication: Reduce risk of COPD exacerbations Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor GOLD 2019
exacerbations Drug Class ... Therapy (LAMA/LABA/ICS ... Dosing: 250 mcg tablet ... GOLD guidelines ... low, adding an ICS
First-line therapies for Asthma, Asthma-COPD Overlap and COPD The diagnosis of COPD, asthma, and ACO initially requires
Asthma, Asthma-COPD ... Overlap and COPD ... initially requires an evaluation ... identification of the type ... #Differences #Algorithm
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment algorithms ... limitation, further evaluation ... Management #Pulmonary #COPD ... GOLD2017 #LAMA #LABA #ICS ... #Guidelines
empty